Portal opens: September 23, 2024
Deadline: October 4, 2024
CARB-X is offering funding across four key themes to combat antimicrobial resistance (AMR):
- Therapeutics for Gram-Negative Pathogens: Seeking new treatments targeting drug-resistant gram-negative bacteria.
- Prevention of Invasive Diseases: Innovations to prevent the spread and development of severe infections.
- Diagnostics for Neonatal Sepsis: Advanced, rapid diagnostics for early detection of sepsis in newborns.
- Alternative Sample Types for Lower-Respiratory-Tract Infections: Proof-of-concept studies for innovative sample types to improve diagnostic accuracy.
For more information and to submit your proposal, please visit the carb-x website.
